TheranosticTrials.org

Clinical Trial · NCT06600399

Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma

Overview

Evaluating the relationship between prostate-specific membrane antigen positron emission tomography and arterial spin labeling perfusion imaging, and the correlation with prostate-specific membrane antigen expressed on glioblastoma microvascular.

Sponsor

Nantes University Hospital

ClinicalTrials.gov

NCT06600399

Eligibility

Inclusion

Inclusion criteria not yet provided.

Exclusion

  • The patient has a serious underlying disease or mental illness and is unable to cooperate with the imaging examination;
  • The image data is of poor or incomplete quality;
  • pregnant women;
  • Have received systematic chemotherapy;